logo

For the Inventor, By the Inventor

Göteborg, Sweden

Lars Baltzer

USPTO Granted Patents = 10 

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Göteborg, SE (2001 - 2010)
  • Uppsala, SE (2011 - 2016)

Company Filing History:

goldMedal7 out of 7 
 
Modpro Ab
 patents
silverMedal2 out of 5 
 
Pharmasurgics in Sweden Ab
 patents
bronzeMedal1 out of 832,912 
Other
 patents

Years Active: 2001-2016

Loading Chart...
10 patents (USPTO):Explore Patents
1. 9377466 - Compounds and methods (2016-06-28),
2. 8436138 - Binder for C-reactive protein (2013-05-07),
3. 8017347 - Binder for C-reactive protein (2011-09-13),
4. 7803757 - Peptides based on the sequence of human lactoferrin and their use (2010-09-28),
5. 7569661 - Polypeptide scaffolds and use thereof (2009-08-04),
6. 7514222 - Site selective acylation (2009-04-07),
7. 7364889 - Catalytically active peptides (2008-04-29),
8. 7253143 - Peptides based on the sequence of human lactoferrin and their use (2007-08-07),
9. 7230072 - Site-selective acyl transfer (2007-06-12),
10. 6171819 - Acyl transfer with stabilized transition complex using catalyst with catalytic imidazole (e.g. histidine) function (2001-01-09),

Title: Lars Baltzer: Innovator in Molecular Tools and Therapeutics

Introduction

Lars Baltzer is a prominent inventor based in Göteborg, Sweden, known for his significant contributions to the field of molecular tools and therapeutics. With a total of 10 patents to his name, he has made remarkable advancements that have the potential to impact various therapeutic applications.

Latest Patents

Among his latest patents, one notable invention is a molecular tool designed for providing a molecule capable of binding a target molecule based on a set of polypeptides. This invention includes a polypeptide with a sequence selected from SEQ ID NOs 1-32, which can be utilized in screening for a ligand-polypeptide conjugate that binds to a target molecule. This ligand-polypeptide conjugate holds promise for therapeutic use. Another significant patent is for isolated polypeptides that specifically bind to C-reactive protein (CRP). This patent discloses a library of isolated polypeptides comprising sequences from SEQ ID NOs 3-18, along with compositions that include these polypeptides.

Career Highlights

Lars has worked with several companies throughout his career, including Modpro AB and Pharmasurgics in Sweden AB. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of molecular therapeutics.

Collaborations

Lars has collaborated with notable individuals in his field, including Lars A. Hanson and Inger Mattsby-Baltzer. These collaborations have fostered a creative environment that has led to the development of groundbreaking inventions.

Conclusion

Lars Baltzer's contributions to the field of molecular tools and therapeutics highlight his innovative spirit and dedication to advancing science. His patents and collaborations reflect a commitment to improving therapeutic options and enhancing our understanding of molecular interactions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…